Shoshana Shendelman - 07 Jan 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Shoshana Shendelman
Issuer symbol: APLT
Transactions as of: 07 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 11 Jan 2022, 17:45:20 UTC
Previous filing: 11 Jan 2022
Next filing: 27 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLT	Common Stock	Award	$0	+120,900	+25%	$0.000000	606,086	07 Jan 2022	Direct	F1
holding	APLT	Common Stock						1,750,000	07 Jan 2022	See footnote	F2
holding	APLT	Common Stock						1,492,094	07 Jan 2022	See footnote	F3
holding	APLT	Common Stock						709,720	07 Jan 2022	See footnote	F4
holding	APLT	Common Stock						290,280	07 Jan 2022	See footnote	F5
holding	APLT	Common Stock						88,397	07 Jan 2022	See footnote	F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLT	Employee Stock Option (Right to Buy)	Award	$0	+80,600		$0.000000	80,600	07 Jan 2022	Common Stock	80,600	$4.17	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 7, 2023, and one-twelfth (1/12th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each quarter thereafter, subject to the Reporting Person continuing to provide services through each such date.
F2	Through a grantor retained annuity trust.
F3	Through a family trust controlled by the reporting person's spouse.
F4	Through the reporting person's spouse.
F5	Through a family trust controlled by the reporting person.
F6	Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
F7	Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.